Literature DB >> 23760487

Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment.

Francesco Pantano, Francesco Maria Guida, Caterina Vivaldi, Bruno Vincenzi, Enrique Grande, Mercedes Rodriguez Garrote, Michele Caraglia, Nicola Silvestris, Enrico Vasile, Gianluca Masi, Alfredo Falcone, Giuseppe Tonini, Daniele Santini.   

Abstract

Entities:  

Keywords:  FBG; TTP; anti-EFGR; body mass index; cancer; cetuximab; colorectal cancer

Mesh：

Substances：

Year:  2013        PMID： 23760487      PMCID： PMC3813561          DOI： 10.4161/cbt.24346

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  2 in total

Review 1.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.

Authors:  Eugenia E Calle; Rudolf Kaaks
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

2.  Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.

Authors:  Mario Scartozzi; Alessandra Mandolesi; Riccardo Giampieri; Chiara Pierantoni; Fotios Loupakis; Alberto Zaniboni; Eva Galizia; Lucio Giustini; Rosa Rita Silva; Renato Bisonni; Rossana Berardi; Simona Biagetti; Stefano Menzo; Alfredo Falcone; Italo Bearzi; Stefano Cascinu
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396
  2 in total
  2 in total

1.  Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon.

Authors:  M Agostina Santoro; R Eric Blue; Sarah F Andres; Amanda T Mah; Laurianne Van Landeghem; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

2.  2-Deoxyglucose Reverses the Promoting Effect of Insulin on Colorectal Cancer Cells In Vitro.

Authors:  Dongsheng Zhang; Qiang Fei; Juan Li; Chuan Zhang; Ye Sun; Chunyan Zhu; Fengzhen Wang; Yueming Sun
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.